Public health safety
First country in Latin America to sign a bilateral supply agreement thus expanding access to the monkeypox vaccine beyond the availability of vaccines through PAHO Additional supply agreement also signed with PAHO to expand availability for its member countries COPENHAGEN, Denmark, October 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced…
A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators aim to enroll more than 500 people from clinical research sites nationwide. Interested volunteers can visit the ACTG website (clinical trial A5418)…
Vientiane,Laos PDR, July 24, 2022 /LienTeh/ Yesterday,World Health Organization(WHO) declares fast spreading monkeypox outbreak a global health emergency.[1] Several pharmaceutical companies that reached the plan through the ALBA TEAM mechanism urgently convened relevant responsible persons for a brief discussion on Sunday, and decided to start the development of the manufacturing formula and…
Reprint News release (On Monday, May 23) EPA triggered its emerging viral pathogen (EVP) guidance in response to recent cases of Monkeypox in the United States. When rare or novel viruses cause outbreaks of disease, there may be few if any disinfectants that have been registered for use against that…
In view of the increasing reports of Monkeypox (MPX) cases in non-endemic countries, as part of a proactive and risk-based approach for management of Monkeypox and to ensure advance preparedness across the country, Union Ministry of Health and Family Welfare has issued ‘Guidelines on Management of Monkeypox Disease’. There are…
Reprint News release (STOCKHOLM, May 27) - The European Union is working on a common purchasing agreement for vaccines and antiviralsagainst monkeypox, as cases of the viral disease usually endemic to Africa gather steam in Europe and beyond. A broad consensus was reached in principle with member states for the…
Reprint News release (SEOUL, South Korea, May 25, 2022) Hyundai Bioscience will go straight to the US with its broad-spectrum antiviral drug candidate to treat monkeypox. Hyundai Bioscience has decided to submit a request for a fast track processing to the U.S. Food and Drug Administration (FDA) for CP-COV03, an oral antiviral medicine…
Reprint News release (May 25, 2022 03:00 AM Eastern Daylight Time) DAVOS, Switzerland--Pfizer Inc. (NYSE: PFE) today launched ‘An Accord for a Healthier World.’ This groundbreaking initiative aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in the U.S. or the European Union on a not-for-profit basis to 1.2…
Reprint News release (28 November 2017) WHO urges governments to take action An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from WHO. This means that people are taking medicines that fail to treat or prevent disease. Not…
Vientiane,Laos PDR, May 21, 2022 /LienTeh/ Yesterday,Members of several leading pharmaceutical companies in Laos discussed the spread of monkeypox and reached a preliminary plan. Companies involved in the formulation of the plan include:RxLibra、SaiLin-Bio、BioSpring、DAXIONG Pharma...etc. The above companies initially selected Tecovirimat as the treatment drug for monkeypox, and started to study the production…
TOKYO, November 5, 2021 Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it obtained approval from the Ministry of Health, Labour and Welfare (MHLW) for the anti-SARS-CoV-2 monoclonal antibody RONAPREVE® [generic name: casirivimab (genetical recombination) /imdevimab (genetical recombination)] for the additional indication of the prevention of symptomatic SARS-CoV-2 infection (COVID-19). The Special…
KENILWORTH, N.J. & MIAMI--November 4, 2021 Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization in the United Kingdom (U.K.) for molnupiravir (MK-4482, EIDD-2801), the first oral antiviral…
October 20, 2021 Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:…
MIAMI, Oct. 19, 2021 Intrivo announced today the launch of On/Go™, an at-home rapid COVID-19 antigen self-test that delivers results with 95% accuracy in just 10 minutes. On/Go, which has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), is an affordable and easy-to-use self-test with a…
ALBA Lighting:Covid-19 infection Patient Assistance Programs abbreviated as "ALBA Lighting PAP". Project objectives The ALBA Lighting PAP aims to help coronavirus infected patients who lack medical resources during the COVID-19 pandemic. Project application conditions The applicant must satisfied the following basic conditions, medical conditions and economic conditions at the same…
संकलन उद्देश्य विश्वव्यापी कोरोनाभाइरस (कोविड १)) महामारी को समयमा, हामीले अविकसित देशहरु र क्षेत्रहरु मा साधारण मानिसहरुलाई नर्सि nursing ज्ञान प्रदान गर्नु पर्छ चिकित्सा स्रोतहरु को उपयोग को लागी क्रम मा जीवित रहने दर सुधार गर्न को लागी। यो गाइड एक अस्थायी गाइड हो। यदि तपाइँ चिकित्सा संगठनहरु बाट सहयोग…